Francisco Rivas-Larrauri

Francisco Rivas-Larrauri

Auto-generated profile, based on publicly available information

Francisco Rivas-Larrauri

Servicio de Inmunología; Instituto Nacional de Pediatría, Mexico

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2019 in Rheumatology International
Verified
Journal Article
Closed access
FRFrancisco Rivas-Larrauri
Francisco Rivas-Larrauri
LALorena Aguilar-Zanela
Lorena Aguilar-Zanela
PCPaola Castro-Oteo
Paola Castro-Oteo
LHLuis Adrián Rosales Hernández
Luis Adrián Rosales Hernández
FOFrancisco Otero-Mendoza
Francisco Otero-Mendoza
MYMarco Yamazaki-Nakashimada
Marco Yamazaki-Nakashimada

20 October 2022 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
ELEduardo Liquidano-Perez
Eduardo Liquidano-Perez
GMGibert Maza-Ramos
Gibert Maza-Ramos
JSJosé Luis Salazar-Bailón
José Luis Salazar-Bailón
MYMarco Yamazaki-Nakashimada
Marco Yamazaki-Nakashimada
FRFrancisco Rivas-Larrauri
Francisco Rivas-Larrauri

2 April 2022 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
BGBeatriz Bayardo Gutierrez
Beatriz Bayardo Gutierrez
MYMarco Yamazaki-Nakashimada
Marco Yamazaki-Nakashimada
ARAna Luisa Rodríguez-Lozano
Ana Luisa Rodríguez-Lozano
GGGilberto Gómez-Garza
Gilberto Gómez-Garza
FRFrancisco Eduardo Rivas-Larrauri
Francisco Eduardo Rivas-Larrauri
SSSelma Cecilia Scheffler-Mendoza
Selma Cecilia Scheffler-Mendoza

29 July 2025 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
FRFrancisco Rivas-Larrauri
Francisco Rivas-Larrauri
JBJuan Carlos Bustamante-Ogando
Juan Carlos Bustamante-Ogando
MGMelissa Golubov-Mandujano
Melissa Golubov-Mandujano
SSSelma Scheffler-Mendoza
Selma Scheffler-Mendoza
ARAna Luisa Rodríguez-Lozano
Ana Luisa Rodríguez-Lozano
MYMarco Yamazaki-Nakashimada
Marco Yamazaki-Nakashimada

10 June 2024 in Children
Verified
Journal Article
Open access
PDF file
MOMiguel Angel Alcántara Ortigoza
Miguel Angel Alcántara Ortigoza
ARAna Luisa Rodríguez-Lozano
Ana Luisa Rodríguez-Lozano
BEBernardette Estandia
Bernardette Estandia
AAAriadna González-del Angel
Ariadna González-del Angel
LDLuisa Díaz-García
Luisa Díaz-García
RNRuth Guadalupe Nájera-Velázquez
Ruth Guadalupe Nájera-Velázquez
A ~3-kb deletion-type DNA copy number variation (CNV, esv3587290) located at intron 7 of the VANGL1 gene (1p13.1, MIM*610132) has been proposed as a genetic factor in lupus nephritis (LN) development in adult systemic lupus erythematosus (SLE) patients across European-descent populations, but its replication in other ethnicities has been inconsistent and its association with LN in childhood-onset SLE (cSLE) remains unknown. Here, we performed an exploratory association study in a sample of 66 unrelated cSLE Mexican patients (11 males, 55 females; ages 7.8 to 18.6 years). Two stratified groups were compared: cSLE patients with (N = 39) or without (N = 27) LN, as diagnosed by renal biopsy (N = 17), proteinuria (N = 33), urinary protein–creatinine ratio > 0.2 (N = 34), and erythrocyturia and/or granular casts in urinary sediment (N = 16). For esv3587290 CNV genotyping, we performed an end-point PCR assay with breakpoint confirmation using Sanger sequencing. We also determined the allelic frequencies of the esv3587290 CNV in 181 deidentified ethnically matched individuals (reference group). The obtained genotypes were tested for Hardy–Weinberg equilibrium using the χ2 test. Associations between LN and esv3587290 CNV were tested by calculating the odds ratio (OR) and using Pearson’s χ2 tests, with a 95% confidence interval and p ≤ 0.05. The esv3587290 CNV allele (OR 0.108, 95% CI 0.034–0.33, p = 0.0003) and the heterozygous genotype (OR 0.04, 95% CI 0.119–0.9811, p = 0.002) showed a significant protective effect against LN development. Finally, we characterized the precise breakpoint of the esv3587290 CNV to be NG_016548.1(NM_138959.3):c.1314+1339_1315-897del in our population. This report supports the notion that a broad genetic heterogeneity underlies the susceptibility for developing LN.

25 November 2023 in Journal of Genetics
Verified
Journal Article
Closed access
PDF file
LCLina M. Castano-Jaramillo
Lina M. Castano-Jaramillo
FLFrancisco Rivas Larrauri
Francisco Rivas Larrauri
SSSelma C. Scheffler-Mendoza
Selma C. Scheffler-Mendoza
AGAlonso Gutierrez-Hernandez
Alonso Gutierrez-Hernandez
JOJuan Carlos Bustamante Ogando
Juan Carlos Bustamante Ogando
SRSaúl Oswaldo Lugo Reyes
Saúl Oswaldo Lugo Reyes